Piper Sandler analyst Christopher Raymond raised the firm’s price target on AbbVie (ABBV) to $227 from $220 and keeps an Overweight rating on

Piper Sandler does not anticipate Estee Lauder (NYSE:EL) to provide full-year guidance, but suggests that meeting second fiscal quarter expectations and aiming for sequential improvement in the third fiscal quarter should be achievable.

Piper Sandler raised the firm’s price target on Merit Medical (MMSI) to $116 from $114 and keeps an Overweight rating on the shares after the